Microbial Production of Bioactive Retinoic Acid Using Metabolically Engineered Escherichia coli

Microbial production of bioactive retinoids, including retinol and retinyl esters, has been successfully reported. Previously, there are no reports on the microbial biosynthesis of retinoic acid. Two genes (blh(SR) and raldh(HS)) encoding retinoic acid biosynthesis enzymes [beta-carotene 15,15'-oxygenase (Blh) and retinaldehyde dehydrogenase2 (RALDH2)] were synthetically redesigned for modular expression. Co-expression of the blh(SR) and raldh(HS) genes on the plasmid system in an engineered beta-carotene-producing Escherichia coli strain produced 0.59 +/- 0.06 mg/L of retinoic acid after flask cultivation. Deletion of the ybbO gene encoding a promiscuous aldehyde reductase induced a 2.4-fold increase in retinoic acid production to 1.43 +/- 0.06 mg/L. Engineering of the 5'-UTR sequence of the blh(SR) and raldh(HS) genes enhanced retinoic acid production to 3.46 +/- 0.16 mg/L. A batch culture operated at 37 degrees C, pH 7.0, and 50% DO produced up to 8.20 +/- 0.05 mg/L retinoic acid in a bioreactor. As the construction and culture of retinoic acid-producing bacterial strains are still at an early stage in the development, further optimization of the expression level of the retinoic acid pathway genes, protein engineering of Blh and RALDH2, and culture optimization should synergistically increase the current titer of retinoic acid in E. coli.

Automated summary

Microbial production of bioactive retinoids has been reported, with successful redesign of two genes leading to increased retinoic acid production in Escherichia coli through engineering and culture optimization. Further refinements in gene expression levels and protein engineering may continue to enhance retinoic acid production.